Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Clinical trial NCT05874713 · COMPLETED

Trial details

NCT number: NCT05874713
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human Infections Respiratory Tract Infections Virus Diseases Infection Viral

Start date: 2023-06-07
Primary completion: 2024-04-25
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.